LogiPharma Europe 2023: Wayne Rothman Discusses Problematic Supply Chain Scenarios

As a result, the provider increases its involvement in the country’s pharma sector.

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

A panel examines the gross-to-net bubble across various product mixes, how pricing impacts market access, and more.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

A session investigates the drivers of these shortages and ways to mitigate them.

Breakout session explores how direct-to-patient models shorten the time to diagnosis and therapy to improve patient outcomes.